The Medicine Maker / Power List / 2015

The Power List 2015

That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Power List

Anthony Fauci

Director, National Institute of Allergy and Infectious Diseases, USA

Kiran Mazumdar-Shaw

Chairperson and Managing Director of Biocon, India

Sir Andrew Witty

Chief Executive Officer, GlaxoSmithKline, UK

Arthur D. Levinson

Chief Executive Officer, Calico, USA

Heather Bresch

Chief Executive Officer, Mylan

Raman Singh

President, Mundipharma Asia Pacific, Latin America, Middle East and Africa

Peter Seeberger

Director at the Max-Planck Institute for Colloids and Interfaces, and Professor, Free University of Berlin, Germany

Pascal Soriot

Executive Director and Chief Executive Officer, AstraZeneca

Robin Robinson

Director of Biomedical Advanced Research and Development Authority; Deputy Assistant Secretary for Preparedness & Response, US Department of Health and Human Services

Robert A. Bradway

Chairman and Chief Executive Officer, Amgen

John Talley

Chief Scientific Officer, Euclises Pharmaceuticals

Carsten Brockmeyer

Chief Executive Officer, Formycon AG

Kenneth C. Frazier

Chairman of the Board and Chief Executive Officer, MSD.

Ruth McKernan

Chief Executive, Innovate UK

David Bentley

Vice President and Chief Scientist, Illumina

Severin Schwan

Chief Executive Officer, Roche Group

Carl June

Richard W. Vague Professor in Immunotherapy, Department of Pathology and Laboratory Medicine, University of Pennsylvania, USA

David Baltimore

President Emeritus and Robert Andrews Millikan Professor of Biology, California Institute of Technology, USA

Rino Rappuoli

Former Global Head of Research and Development for Novartis Vaccines

Robert Langer

David H. Koch Institute Professor, Massachusetts Institute of Technology, USA

Lamberto Andreotti

Chief Executive Officer, Bristol-Myers Squibb

Lisa Anson

President, AstraZeneca UK and Ireland

Alan Armstrong

Chairman & Group Chief Executive Officer, Almac Group

John Aunins

Executive Vice President and Chief Technology Officer, Seres Health, USA

Stéphane Bancel

Chief Executive Officer, Moderna Therapeutics

Richard Bergström

Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA)

Olivier Brandicourt

Chief Executive Officer, Sanofi

Barry Buckland

Chief Executive Officer, BiologicB, USA

Pierre Chambon

Professor of Molecular Genetics, Institute of Advanced Studies, Strasbourg University, France

John Chiminski

President and Chief Executive Officer, Catalent

William Chin

Executive Vice President, Scientific and Regulatory Affairs, Pharmaceutical Research and Manufacturers of America (PhRMA)

Marshall Crew

Global PDS Scientific Excellence, Patheon

Francis S. Collins

Director, US National Institutes of Health, USA

Charles Cooney

Robert T. Haslam (1911) Professor of  Chemical Engineering Emeritus, Department of Chemical Engineering, Massachusetts Institute of Technology, USA

Meindert Danhof

Professor of Pharmacology and former Scientific Director of the Leiden Academic Center for Drug Research (LACDR), Leiden University, the Netherlands

Marijn Dekkers

Chairman of the Board of Management, Bayer AG

Sir Andrew Dillon

Chief Executive of the National Institute for Health and Care Excellence (NICE), UK

Joseph Famulare

Vice President, Global Quality Compliance and External Collaboration, Genentech

John P. Farris

President and Chief Executive Officer, SafeBridge Consultants, USA

Dennis Fenton

Retired

Mark C. Fishman

President, Novartis Institutes for Biomedical Research

Chris Frampton

Professor of Structural Chemistry and Crystal Engineering, Wolfson Centre for Materials Processing, Brunel University, UK

Parrish Galliher

Chief Technology Officer, Xcellerex, Life Sciences from GE Healthcare

Kenneth Getz

Director, Sponsored Research Programs and Associate Professor, CSDD, Tufts University School of Medicine; Founder and Board Chair, CISCRP

Dalvir Gill

Chief Executive Officer and Member of the Board of Directors, TransCelerate BioPharma

Jane Griffiths

Company Group Chairman, Janssen EMEA

Yoshihiko Hatanaka

Chief Executive Officer and President, Astellas Pharma

Richard Heyman

Founder, Aragon and Seragon

Robert J. Hugin

Chairman and Chief Executive Officer, Celgene

Ajaz Hussain

Executive Director, The National Institute for Pharmaceutical Technology and Education, USA

Tyler Jacks

David H. Koch Professor; Director, Koch Institute for Integrative Cancer Research; Investigator, Howard Hughes Medical Institute, USA

Dennis R. Jenke

Baxter Distinguished Scientist, Baxter Healthcare Corporation

Joseph Jimenez

Chief Executive Officer, Novartis

William G. Kaelin

Professor of Medicine, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Harvard Medical School; Investigator, Howard Hughes Medical Institute; and Associate Director, Basic Science, Dana-Farber Cancer Institute/Harvard Cancer Center

Jeff Kasher

President, Patients Can’t Wait, LLC

Joseph Kim

Senior Advisor in Clinical Innovation, Eli Lilly

Andreas Koester

Vice President, Clinical Trial Innovation, Janssen R&D, Janssen Pharmaceutical Companies of Johnson & Johnson

Daniel S. Kohane

Professor of Anaesthesia, Harvard Medical School, USA

John C. Lechleiter

Chairman, President and Chief Executive Officer, Eli Lilly and Company

Wim Leereveld

Founder and CEO, Access to Medicine Foundation

Craig Lipset

Head of Clinical Innovation, Worldwide Research & Development, Pfizer

Archie Lovatt

Scientific Operations Director, SGS Life Sciences

Anthony S. Lubiniecki

Senior Scientific Director & Fellow, Chemistry, Manufacturing & Controls (CMC) Strategy, Pharmaceutical Development & Manufacturing Sciences, Janssen R&D

Claus-Michael Lehr

Professor, Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS); Helmholtz Center for Infection Research (HZI); Saarland University, Germany

Louis Monti

Executive Vice-President and Secretary, Pherin Pharmaceuticals

Julian Morris

Emeritus Professor of Process Control, Newcastle University, UK and Technical Director, Centre for Process Analytics and Control Technology (CPACT)

Randy Mrsny

Professor, Department of Pharmacy and Pharmacology, University of Bath, UK

Tarit Mukhopadhyay

Lecturer, Vaccine Bioprocess Development, University College London, UK

Kary Mullis

Chief Scientific Advisor for Altermune Technologies

George Nakayama

Representative Director; President and Chief Executive Officer, Daiichi Sankyo Co., Japan

Mark Offerhaus

Founder and CEO, Micreos, The Netherlands

Julie O’Neill

Executive Vice President, Global Operations, Alexion, Ireland

Stephen Ostroff

Acting Commissioner of Food and Drugs, FDA

Brian Overstreet

Co-Founder and President, AdverseEvents

Ulo Palm

Senior Vice President Branded Drug Development Operations, Actavis Pharmaceuticals

Alain Pralong

VP New Product Introduction & Technical Life Cycle Management, GSK

David E.I. Pyott

Former Chairman and CEO, Allergan

Ian C. Read

Chairman of the Board and Chief Executive Officer, Pfizer

Joerg Reinhardt

Chairman of the Board of Directors, Novartis AG

Tomasz Sablinski

Co-founder & CEO, Transparency Life Sciences

Charles L. Sawyers

Memorial Sloan-Kettering Cancer Center; investigator at Howard Hughes Medical Center, USA

George A. Scangos

Chief Executive Officer, Biogen Idec

Joseph Schlessinger

William H. Prusoff Professor of Pharmacology and Chair of the Pharmacology section, Yale School of Medicine; Director, Yale Cancer Biology Institute

Andreas Seidel-Morgenstern

Director, Department of Physical and Chemical Foundation of Process Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Germany

Andy Skibo

Head of Global Biologics Operations and Global Engineering at AstraZeneca/MedImmune

Manish Soman

President and CEO, Sciformix

Lars Rebien Sørensen

Chief Executive Officer, Novo Nordisk A/S

Indresh K. Srivastava

Vice President, Product Realization, Protein Sciences

Abbe Steel

Founder and CEO, HealthiVibe

Marco Taglietti

CEO, Scynexis, USA

Nigel Theobald

Founder and CEO, N4 Pharma, UK

Bernhardt Trout

Raymond F. Baddour, ScD, (1949) Professor of Chemical Engineering, MIT and Director, Novartis-MIT Center for Continuous Manufacturing, USA

Catherine Tuleu

Director, Centre for Pediatric Pharmacy Research, UCL School of Pharmacy, UK

Harold Varmus

Lewis Thomas University Professor at Weill Cornell Medical College, USA

J. Craig Venter

Founder, Chairman, and CEO of the J. Craig Venter Institute (JCVI), USA

Jens H. Vogel

Global Head, CMC Strategy & TRA, Boehringer Ingelheim Biopharmaceuticals, Germany

J. Michael Wallace

Director, Global Standards & Serialization, Abbott Laboratories, USA

Keith Williams

Founder and Managing Director, GXPi and Formpipe

Vikramaditya G. Yadav

Assistant Professor, Department of Chemical and Biological Engineering, The University of British Columbia, Canada

Shinya Yamanaka

Director and Professor, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan

False

Explore

Featured Topics

Issues

Techniques & Tools

Applications & Fields

News & Blogs

Community & Awards